Pulmonology
Lungs & breathing clinical trials
Asthma, COPD, and other conditions that affect the lungs and breathing. We’re tracking 6,637 recruiting studies in this area right now.
By phase
- Not applicable4,308
- Phase 2850
- Phase 1471
- Phase 3425
- Phase 1/Phase 2309
- Phase 4208
- Phase 2/Phase 366
Top conditions
- Lung Cancer424
- Asthma194
- Non Small Cell Lung Cancer189
- Non-Small Cell Lung Cancer181
- Non-small Cell Lung Cancer172
- Obstructive Sleep Apnea155
- COPD143
- Breast Cancer110
- COVID-19107
- Pulmonary Hypertension100
- NSCLC95
- Chronic Obstructive Pulmonary Disease90
- Colorectal Cancer84
- Pneumonia79
- Cystic Fibrosis78
- Interstitial Lung Disease78
- Acute Respiratory Distress Syndrome72
- Chronic Obstructive Pulmonary Disease (COPD)72
Leading sponsors
- Assistance Publique - Hôpitaux de Paris79
- AstraZeneca65
- Mayo Clinic53
- M.D. Anderson Cancer Center46
- National Cancer Institute (NCI)39
- VA Office of Research and Development39
- Chinese University of Hong Kong36
- Shanghai Chest Hospital36
- University Health Network, Toronto36
- Memorial Sloan Kettering Cancer Center34
Where studies are running
- California393
- Alabama173
- Arizona156
- Massachusetts128
- Florida116
- New York113
- Maryland111
- Texas90
- Pennsylvania83
- Illinois72
Recruiting studies6,637 total
- NCT06472804Recruiting
Insomnia in advanced lung cancer patients
This study looks at how common insomnia (trouble sleeping) is in people with advanced lung cancer. It aims to better understand sleep problems so doctors can help patients sleep better.
Rochester, MinnesotaAges 18 years+ - NCT06474039RecruitingPhase 3
COPD treatment: triple vs. double inhaler for air trapping
This trial tests whether adding a third medicine (fluticasone furoate/vilanterol/umeclidinium) to a two-medicine inhaler (vilanterol/umeclidinium) can reduce air trapping and inflammation in the lungs and blood of people with COPD GOLD B. It may help you breathe better and have fewer symptoms.
Bangkoknoi, BKKAges 40–80 - NCT06475469Recruiting
Immune system in untreated CLL and infection risk
This study looks at how the immune system works in people with untreated CLL and tries to find ways to predict who might get infections. It aims to help doctors better protect patients from infections in the future.
ReimsAges 18 years+ - NCT06475976Recruiting
Identifying lung types in severe BPD in preemies
This study looks at babies born very early who have severe lung disease (grade 3 BPD) and still need a breathing machine. Researchers will use tests to understand their lung problems better, which may help guide their care.
Philadelphia, PennsylvaniaAges 1 month–1 year - NCT06476015Recruiting
Exercise for chronic disease patients
This study looks at whether a physical exercise program can help people with long-term health conditions like COPD or diabetes. If you are 60 to 90 years old and already part of the 'Ser más' program, you may be able to join.
Medellín, AntioquiaAges 60–90 - NCT06476093Recruiting
Radiation plus anlotinib for lung cancer brain spread
This trial tests a combination of focused radiation (stereotactic radiosurgery) and an oral targeted therapy called anlotinib for people with non-small cell lung cancer that has spread to the brain. It may offer a way to control brain metastases without more invasive procedures.
Lianyungang, JiangsuAges 18–80 - NCT06476171Recruiting
Blood test study for heart surgery patients
This study looks at blood test results from people having heart surgery with a heart-lung machine. It will help doctors understand and improve the use of these tests.
MoscowAges 18–80 - NCT06476210RecruitingPhase 4
New drug combo for drug-resistant tuberculosis
This trial tests a three-drug combination (bedaquiline, delamanid, and linezolid) to see if it's safe and works well for people with multi-drug resistant or rifampicin-resistant tuberculosis. It may offer a new treatment option if standard drugs aren't working.
Hefei, AnhuiAges 18 years+ - NCT06476249Recruiting
Cough risk after lung surgery via thoracoscope
This study looks at why some people develop a cough after having part of a lung removed through small cuts (video-assisted thoracoscopic surgery). It may help identify who is more likely to have this side effect.
Kunming, YunnanAges 18–70 - NCT06476470Recruiting
Taiwan ILD registry for understanding lung disease
This registry is gathering information from people with different types of interstitial lung disease (ILD) across Taiwan. It aims to better understand the disease and improve future care.
TaichungAges 18 years+ - NCT06476769Recruiting
Blow bottle and postural drainage for COPD
This study tests whether combining a simple blow-bottle breathing exercise with postural drainage (lying in different positions to help clear mucus) can help people with moderate to severe COPD breathe better. It is designed for older adults who are stable and do not have other major health issues.
Multan Khurd, Punjab ProvinceAges 40–60 - NCT06476808RecruitingPhase 1
Testing a new drug for advanced solid tumors
This trial tests an investigational drug (BMS-986463) in people with advanced solid tumors. It aims to find a safe dose and see if it helps shrink or control the cancer. You must be well enough to do daily activities and have a tumor that can be biopsied before treatment starts.
Los Angeles, CaliforniaAges 18 years+ - NCT06477185RecruitingPhase 2
Preventing lung scarring after TB with doxycycline
This trial tests whether the antibiotic doxycycline can prevent lung scarring (fibrosis) after a serious TB infection. You may be eligible if you are currently being treated for active TB and have significant lung damage on your chest X-ray.
Kampala, KampalaAges 18–65 - NCT06477302Recruiting
Sticking with breathing rehab for lung cancer
This trial looks at how well people with lung cancer stick with a respiratory rehabilitation program (breathing exercises and support). Researchers want to see if factors like your treatment stage or daily function affect your ability to keep up with rehab. It may help find ways to better support patients during recovery.
Mexico City, Mexico CityAges 18 years+ - NCT06477419RecruitingPhase 2
Sacituzumab govitecan for mesothelioma after prior treatment
This study tests a drug called sacituzumab govitecan (a targeted therapy that delivers chemotherapy directly to cancer cells) for people with mesothelioma that has already been treated with other therapies. The goal is to see if the drug can shrink tumors and help control the disease.
Basking Ridge, New JerseyAges 18 years+ - NCT06477861Recruiting
Elastic power predicts ARDS severity and death risk
This study looks at a new way to predict how serious ARDS (a severe lung injury from pneumonia) is and the chance of death. Doctors will measure something called "elastic power" to see if it helps guide treatment for patients on a breathing machine.
Banhā, Al QalubeyahAges 18–65 - NCT06478108RecruitingPhase 2/Phase 3
Software-guided multi-immunotherapy for solid tumors
This trial tests a new software-guided approach to deliver multiple immunotherapy drugs directly into the liver for people with solid tumors. It aims to see if this method can shrink tumors and improve survival.
Guangzhou, GuangdongAges 18–75 - NCT06479473RecruitingPhase 1/Phase 2
Radiation for leftover spots after chemo-immunotherapy in lung cancer
This trial is for people with extensive-stage small cell lung cancer. After standard chemo-immunotherapy, it tests whether giving radiation to all remaining tumor spots can improve outcomes.
Hefei, AnhuiAges 18–70 - NCT06479603RecruitingPhase 4
Nintedanib for lung scarring from sarcoidosis
This trial tests whether nintedanib, a drug that slows lung scarring, can help people with sarcoidosis-related lung fibrosis. It is for those who still have breathlessness or cough despite stable treatment.
ChandigarhAges Any age - NCT06480435Recruiting
Chest physiotherapy and lung squeezing for men with COPD
This study explores whether a chest physiotherapy technique (called lung squeezing) can help men with moderate-to-severe COPD breathe more easily. Participants will receive the therapy and be monitored for improvements.
Lahore, Punjab ProvinceAges 40–60 - NCT06480422Recruiting
Breathing exercises for moderate COPD
This study tests two breathing exercises—autogenic drainage and segmental breathing—to see if they help people with moderate COPD breathe easier. It may help you clear mucus and improve your lung function.
Lahore, Punjab ProvinceAges 40–60 - NCT06480604Recruiting
Probiotic for yeast infection prevention
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
Vadodara, GujaratAges 18–50 - NCT06480864Recruiting
Study of adebelimumab and apatinib for extensive stage small cell lung cancer maintenance
This trial tests whether adding two targeted therapies (adebelimumab, an immunotherapy, and apatinib, a drug that blocks blood vessel growth) after initial chemotherapy can help keep extensive stage small cell lung cancer under control. It is for people who have not yet had systemic treatment for their cancer and are in good enough health to try this maintenance approach.
Shenyang, LiaoningAges 18 years+ - NCT06480994Recruiting
Testing a new tool to help diagnose blood clots
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
Niort, SartresAges 18 years+
Common questions
- How many lungs & breathing clinical trials are recruiting?
- Clin2 is tracking 6,637 recruiting pulmonology studies from the U.S. registry right now, out of 10,624 we cover in this area in total.
- What does “Lungs & breathing” cover here?
- Asthma, COPD, and other conditions that affect the lungs and breathing. We group each study into lungs & breathing based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a lungs & breathing trial near me?
- Use the search to filter lungs & breathing studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.